# Tirofiban for Patients Treated With Alteplase

> **NCT03357133** · PHASE2,PHASE3 · TERMINATED · sponsor: **Capital Medical University** · enrollment: 30 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Tirofiban
- **DRUG:** Alteplase

## Key facts

- **NCT ID:** NCT03357133
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-16
- **Primary completion:** 2020-06-01
- **Final completion:** 2020-08-31
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** The number and speed of enrollment were significantly less than expected.
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03357133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03357133, "Tirofiban for Patients Treated With Alteplase". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03357133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*